Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/103316
Title: Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia
Authors: Rodrigues, João E.
Martinho, Ana
Santa, Cátia 
Madeira, Nuno 
Coroa, Manuel 
Santos, Vítor 
Martins, Maria J. 
Pato, Carlos N. 
Macedo, António 
Manadas, Bruno 
Keywords: proteomics; mass spectrometry; schizophrenia; biomarkers; human peripheral fluids
Issue Date: 28-Apr-2022
Project: POCI-01-0145-FEDER-30943 (ref.: PTDC/MEC-PSQ/30943/2017) 
POCI-01- 0145-FEDER-016428 (ref.: SAICTPAC/0010/2015), POCI-01-0145-FEDER-016795 (ref.: PTDC/NEUSCC/ 7051/2014) 
UIDB/04539/2020 
UIDP/04539/2020. 
SFRH/BD/88419/2012 
Serial title, monograph or event: International Journal of Molecular Sciences
Volume: 23
Issue: 9
Abstract: Mass spectrometry (MS)-based techniques can be a powerful tool to identify neuropsychiatric disorder biomarkers, improving prediction and diagnosis ability. Here, we evaluate the efficacy of MS proteomics applied to human peripheral fluids of schizophrenia (SCZ) patients to identify disease biomarkers and relevant networks of biological pathways. Following PRISMA guidelines, a search was performed for studies that used MS proteomics approaches to identify proteomic differences between SCZ patients and healthy control groups (PROSPERO database: CRD42021274183). Nineteen articles fulfilled the inclusion criteria, allowing the identification of 217 differentially expressed proteins. Gene ontology analysis identified lipid metabolism, complement and coagulation cascades, and immune response as the main enriched biological pathways. Meta-analysis results suggest the upregulation of FCN3 and downregulation of APO1, APOA2, APOC1, and APOC3 in SCZ patients. Despite the proven ability of MS proteomics to characterize SCZ, several confounding factors contribute to the heterogeneity of the findings. In the future, we encourage the scientific community to perform studies with more extensive sampling and validation cohorts, integrating omics with bioinformatics tools to provide additional comprehension of differentially expressed proteins. The produced information could harbor potential proteomic biomarkers of SCZ, contributing to individualized prognosis and stratification strategies, besides aiding in the differential diagnosis.
URI: https://hdl.handle.net/10316/103316
ISSN: 1422-0067
DOI: 10.3390/ijms23094917
Rights: openAccess
Appears in Collections:I&D CIBB - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais
IIIUC - Artigos em Revistas Internacionais
I&D CIBIT - Artigos em Revistas Internacionais

Show full item record

SCOPUSTM   
Citations

9
checked on Mar 25, 2024

WEB OF SCIENCETM
Citations

7
checked on Mar 2, 2024

Page view(s)

73
checked on Mar 26, 2024

Download(s)

116
checked on Mar 26, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons